Protein

Protein is the single nutrient where naïve reading of cohort data and naïve reading of mechanistic biology give the most contradictory advice. Cohorts repeatedly suggest "low protein extends lifespan." Trainers, sports scientists, and the geriatric literature insist midlife and older adults need more protein, not less. Both readings are correct in their own demographic, and the 2024–2026 mechanistic literature now explains why. The article walks the resolved version.

The biochemistry, briefly

Two opposing nutrient-sensing enzymes sit at the centre of the cell's anabolic-vs-catabolic decision. The full mechanism — and how it sets the rate of ageing — lives under deregulated nutrient sensing; what follows is the short version the protein argument needs.

mTOR (mechanistic target of rapamycin) — the anabolic, pro-growth sensor. Its mTORC1 complex integrates growth factors, energy status, and — most importantly here — amino acid availability, and the single most potent nutrient trigger is the branched-chain amino acid leucine.^[1] Once active, mTORC1 drives protein synthesis and the building of new ribosomes — and simultaneously switches off autophagy, the cell's recycling-and-cleanup program.^[2]

AMPK (AMP-activated protein kinase) — the catabolic, low-fuel sensor. It responds to a falling energy charge (fasting, caloric deficit, mechanical loading), and when active it stimulates glucose uptake, fat oxidation, and the building of new mitochondria, switches mTORC1 off, and initiates autophagy.^[3]

The hyperfunction theory of ageing — that ageing is the unabated continuation of growth programs into late life — treats chronic mTORC1 activation as the central pathological signal, with AMPK activation (via fasting, exercise, or a low energy state) as its physiological counterweight.^[4] Both extremes are pathological: continuous anabolic drive accelerates atherosclerosis, cancer, and senescence; continuous catabolic drive produces frailty, sarcopenia, and immune failure.

The leucine threshold and the macrophage problem

Two numbers anchor everything that follows.

Number one — the "muscle full" threshold. Maximally stimulating muscle protein synthesis (MPS) in a single meal requires roughly 2.5–3.0 g of leucine reaching the systemic circulation, which is delivered by 0.4 g of high-quality protein per kg body weight (~25–30 g for an average adult) per meal.^[5] Beyond this dose, MPS saturates. Doubling the protein in one sitting doesn't double the synthesis response.^[6]

Number two — the macrophage threshold. The dose that saturates MPS sits immediately adjacent to the dose that activates mTORC1 in macrophages, with downstream vascular consequences. Eating more than ~25 g protein per meal, or chronically more than ~22% of total energy as protein, raises postprandial plasma leucine into the 100–300 μM window that drives macrophage mTORC1 activation.^[7] The mechanism matters: macrophages need autophagy to clear oxidised LDL from the arterial wall, and mTORC1 activation shuts that autophagy off. Macrophages unable to clear their lipid cargo become foam cells; foam cells become atherosclerotic plaques. In murine atherosclerosis models, dietary leucine content alone accounted for the entire between-group variance in macrophage mTORC1 activation and plaque burden.

Read together, the two thresholds explain why "more protein is always better" is wrong without being correctly summarised as "less is better." The dose that drives muscle hypertrophy sits right at the edge of the dose that drives vascular aging. Eating it once or twice a day around training is one regime; eating it every meal in 60–80 g servings is a different drug.

What the human data actually says

The age-dependent flip. In a 6,381-adult analysis of US national nutrition survey data, high protein intake in adults aged 50–65 was associated with 4× higher cancer mortality and 75% higher all-cause mortality — an effect driven by animal protein.^[8] Above age 65 the relationship inverts, and high protein becomes protective. This single age-dependent flip is the most consistent feature of the longevity-protein literature and frames everything else.

The plant vs animal IGF-1 paradox. It's widely assumed animal protein raises IGF-1 more than plant protein. Tightly controlled isocaloric high-protein trials disagree: plant and animal protein produced similar increases in bioavailable IGF-1 and similar improvements in liver fat, insulin sensitivity, and adiposity.^[9] The longevity advantage of plant protein is therefore probably not about lower IGF-1 in absolute terms. The likelier drivers are differences in methionine and leucine density (next section), the surrounding food matrix (fibre, phytochemicals, lower saturated fat), and the carcinogen exposure that comes with red and processed meat specifically — not a generic "plant = less anabolic" effect.

The ceiling for healthy training adults. Intakes up to 1.6 g/kg/day support performance and recovery in active adults without metabolic detriment.^[10] This is the upper bound for healthy training adults that the bodybuilding community routinely exceeds — without supporting evidence that the excess does more good than harm.

The older-adult consensus. Adequate protein in older adults protects against sarcopenia, frailty, and falls. The international expert consensus is 1.0–1.2 g/kg/day for healthy older adults, rising to 1.2–1.5 g/kg with chronic illness or convalescence and up to 2.0 g/kg during acute recovery or severe malnutrition.^[11][12] The historical RDA of 0.83 g/kg is widely viewed as inadequate for skeletal preservation past midlife.

Macronutrient ratio matters, not just total protein. In DNA-repair-deficient mice — a model of accelerated ageing — a high-protein, low-carbohydrate diet shortened lifespan by 18% in males and 36% in females, driven by mitochondrial dysfunction and systemic inflammation, while low-fat/high-carbohydrate and low-protein/high-carbohydrate diets had no lifespan-shortening effect.^[13] The implication isn't that protein is poison — it's that protein at the expense of carbohydrate, especially in a sedentary context, is not the longevity diet.

The age-dependent pivot

The single most useful frame in this literature is that protein recommendations flip somewhere in late middle age.

Anabolic resistance is the mechanism behind the late-life pivot. Older skeletal muscle is materially less responsive to a given dose of amino acids; reaching the leucine threshold for MPS requires a larger absolute amino acid load.^[14] The result: the same 20 g protein that fully stimulates MPS in a 30-year-old reaches only a fraction of maximum response in a 75-year-old. The geriatric per-meal target of 30–40 g — and the recommendation to add a pre-sleep protein feed of ~40 g to counteract the overnight catabolic window — is downstream of that physiology.^[15]

Protein source: why plant generally beats red meat, mechanistically

The clearest mechanistic case against red and processed meat in volume runs through two channels: amino acid composition (specifically methionine and leucine density) and direct carcinogenicity of preservation byproducts.

Methionine restriction and the methylation cycle

Methionine is a sulfur-containing essential amino acid that is highly concentrated in skeletal muscle meat, poultry, eggs, and dairy, and notably scarce in legumes. Across yeast, flies, rodents, and primates, restricting dietary methionine — independent of total caloric restriction — extends lifespan and improves metabolic health.^[16] The mechanism: methionine is the precursor for S-adenosylmethionine (SAM), the cell's universal methyl donor. High SAM directly stimulates mTORC1; low SAM is read as nutrient deprivation and suppresses it. Methionine restriction also induces FGF21, raising energy expenditure via brown-fat uncoupling.

The processed and red meat case

The colorectal cancer signal for processed and unprocessed red meat is independent of the mTOR story and has stood up across cohorts. Each 50 g/day of processed meat associates with a ~16–18% increase in colorectal cancer risk, and each 100 g/day of unprocessed red meat with about a 17% increase.^[17] Processed meat is IARC Group 1 (carcinogenic to humans); unprocessed red meat is Group 2A (probably carcinogenic). See Foods to limit for the wider harm signal beyond what protein per se contributes.

A more useful comparison table

Leucine and methionine content vary widely across protein sources, and that variation — not total grams — is what shifts a source's longevity-versus-hypertrophy profile.^[18]

The practical reading: lean fish, eggs, yogurt, and poultry sit in a different category from red and especially processed meat. The "animal protein is bad" blanket has always been an over-read of cohorts that mostly measured red and processed meat consumption.

Glycine, collagen, and the methionine buffer

The cleanest practical lever for omnivores is glycine.

Glycine is abundant in connective tissue (collagen, gelatin, skin, bone, bone broth) and largely absent from modern Western diets that rely on skeletal muscle meat. The hepatic enzyme glycine N-methyltransferase (GNMT) clears excess methionine by transferring a methyl group from SAM onto glycine, producing sarcosine. Dietary glycine therefore acts as a SAM-buffering, methionine-restriction mimetic.^[19]

In the NIH Interventions Testing Program, 8% dietary glycine extended lifespan in male and female heterogeneous mice across three independent test sites — a high bar for replication.^[20] Sarcosine, the GNMT methylation product, declines with age and independently induces autophagy in vitro and in vivo.

The practical version: if your protein backbone is meat-heavy, eat the connective tissue too — bone broth, slow-cooked stews with cartilaginous cuts, gelatin desserts, or 5–10 g of plain glycine or hydrolysed collagen daily. The collagen isn't building your tendons via mystical mechanism; the glycine is buffering your methylation cycle.

Practical protein targets

Daily total

• Sedentary midlife adult: 0.8–1.0 g/kg/day
• Active midlife adult: 1.2–1.6 g/kg/day
• Older adult (≥65): 1.0–1.5 g/kg/day
• Hypertrophy phase, or older adult with chronic illness: 1.6–2.0 g/kg/day
• On a GLP-1 receptor agonist: aim for the upper end (1.6–2.2 g/kg/day) to defend against muscle loss in the drug-induced caloric deficit. See Ozempic-class drugs.

A 75 kg person at the active-midlife target lands in the 90–120 g/day band; an older adult on the geriatric target lands in the 75–115 g/day band depending on health status.

Per-meal distribution

• Target ~0.4 g/kg per meal (≈25–30 g for most adults), enough to deliver the 2.5–3.0 g leucine "muscle full" threshold.
• Distribute across 3–4 meals, not loaded into one or two.
• Older adults: per-meal dose rises to 30–40 g to overcome anabolic resistance.
• Add a pre-sleep ~30–40 g feed, particularly if older or in a hypertrophy phase — overnight is the longest catabolic window of the day, and pre-sleep casein or a similar slow-release source improves overnight protein balance.^[21]
• Don't routinely exceed ~25–30 g per meal multiple times a day unless you're training around it. Eating 60–80 g of red meat in one sitting overshoots the MPS ceiling and pushes plasma leucine into the macrophage-mTORC1 window.

Source priorities

Anchor the backbone with: fish, legumes (with or without grain pairing), yogurt and kefir, eggs, poultry, soy (tofu, tempeh, edamame), nuts and seeds.

Use occasionally: lean red meat (1–3 servings/week is a reasonable upper bound; lower if family history of CRC or CVD), cheese in small amounts, whey or plant protein powder around training.

Limit aggressively: processed meats (Group 1 carcinogen — see Foods to limit for the dose-response).

Add intentionally: glycine via bone broth, gelatin, or plain glycine/collagen powder (5–10 g/day) if your animal protein intake is meat-heavy.

Protein and training

Around resistance sessions

Resistance exercise transiently activates AMPK locally (the muscle is in an energy crisis during contraction) and only swings into the mTOR-dominant, MPS-driven repair phase once exogenous amino acids arrive.^[22] The practical implication:

• 20–40 g of high-quality protein within ~2 hours of a resistance session — this is the window where the "muscle full" leucine threshold actually buys muscle, because the mechanical stimulus has primed the tissue. Whey is fast and complete; food works fine if you eat a normal protein-containing meal within the window.
• Per-session leucine ~2.5–3.0 g — corresponds to ~25 g whey or ~40 g most whole-food sources.
• The exact post-workout window is wider than the legacy "30-minute" claim implies (the anabolic window is hours, not minutes), but the closer you sit to the session the better.

Concurrent training: split the AMPK and mTOR stimuli on purpose

For people doing both endurance and resistance work, the most efficient signalling design is to separate the two physiological states rather than blur them.^[23]

• Zone 2 / longer aerobic sessions in a fasted or near-fasted state maximise AMPK activation, autophagic flux, mitochondrial biogenesis, and fat oxidation. Don't pre-load these with protein.
• Resistance training paired with post-workout protein localises mTOR activation specifically to the trained muscle, minimising systemic / vascular spillover. Don't waste the leucine bolus on cardio.
• Stacking the two on the same day, or on alternate days, both work; the principle is to avoid burying the AMPK window under continuous protein feeding.

See Resistance training for programming, Zone 2 for the aerobic side, and VO₂ max for the higher-intensity component.

BCAA supplements

Isolated branched-chain amino acid supplements (leucine, isoleucine, valine) are less effective than whole protein for muscle building. Whole protein delivers the BCAAs alongside the other essential amino acids actually required to assemble a complete protein; BCAAs alone trigger the mTOR signal without supplying the full set of building blocks, so the synthesis response is limited and can even draw on muscle breakdown to fill the gaps.^[24] The supplement industry's enthusiasm for BCAAs is older than the evidence justifying it.

Cyclical eating: TRF, protein cycling, and why blind restriction fails

Why the chronic state matters

Continuous feeding from morning to night keeps mTORC1 downstream signalling chronically elevated and AMPK chronically suppressed. The diurnal AMPK/mTOR oscillation flattens. NAD⁺ pools deplete, sirtuin activity drops, and chromatin biases toward epigenetic drift.^[25]

Time-restricted eating — confining all caloric intake to a consistent 8–12 hour window — restores that oscillation without requiring any change in total calories or protein.^[26] During the fasting window, AMPK rises sharply, autophagic flux increases, and NAD⁺ normalises. When food returns, mTOR activation is sharper and more efficient, not duller — exactly the response training-adapted tissue can use. See Fasting and time-restricted eating for the full evidence on protocols, durations, and who shouldn't fast.

Protein cycling

Once daily intake is appropriate for your life stage, an additional layer is one or two deliberately low-protein days per week — intake suppressed below ~0.8 g/kg, with calories from carbohydrate and fat. The intent is to drop systemic leucine for long enough to fully re-enable macrophage autophagy and intensify the AMPK-driven cleanup pulse, without losing skeletal muscle — resistance training maintains the muscle through brief amino acid deficits. The evidence for protein cycling as a discrete intervention is thin: unlike time-restricted eating, it has no dedicated human-outcome trials, and the rationale is extrapolated from the leucine-threshold and autophagy biology above. It's reasonable for people who tolerate it and keep a training stimulus, but it isn't established.

Why "just eat less protein" backfires

The Protein Leverage Hypothesis is the most important behavioural fact in this literature. Humans regulate protein intake to a roughly fixed daily target; if the diet is protein-dilute, total calorie intake rises until that target is met.^[27] "Eat less protein for longevity" advice in the context of an ultra-processed, protein-dilute food environment doesn't reduce protein intake; it produces hyperphagia and obesity, and the obesity does the damage. Structured restriction (TRF, protein cycling) works around this; blind restriction does not.

What's overhyped, and what's just wrong

Overhyped

• Massive protein doses every meal. Beyond ~0.4 g/kg per meal, MPS saturates. Each additional gram is just providing fuel for postprandial leucine elevation in macrophages.
• BCAA supplements for muscle building, as discussed above. Whole protein wins on every clinical endpoint.
• "Animal protein is bad" as a blanket claim. Fish, eggs, yogurt, and poultry have favourable cohort data; the harm signal lives specifically in red and processed meat.

Just wrong

• The 0.83 g/kg RDA in midlife and older adults. The international consensus is well above this; the RDA is a minimum-not-to-fall-into-overt-deficiency, not an optimum.
• "Protein damages kidneys." True only in pre-existing chronic kidney disease. In healthy kidneys, intakes well above the RDA are tolerated long-term without nephrotoxicity. Don't fear protein because you read a 1990s cohort.
• "You can only absorb 30 g per meal." Conflates absorption with MPS. The body absorbs more than 30 g; what saturates around 25–40 g is muscle protein synthesis specifically. Excess is metabolised, oxidised, or — see the macrophage section — channelled into less helpful places.

Further reading

• Levine ME et al. Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population. Cell Metab 2014.^[28]
• Phillips SM, Chevalier S, Leidy HJ. Protein "requirements" beyond the RDA. Appl Physiol Nutr Metab 2016.^[29]
• Bauer J et al. Evidence-based recommendations for optimal dietary protein intake in older people: PROT-AGE position paper. J Am Med Dir Assoc 2013.^[30]
• Schoenfeld BJ, Aragon AA. How much protein can the body use in a single meal for muscle-building? J Int Soc Sports Nutr 2018.^[31]
• Zhang Y et al. Identification of a leucine-mediated threshold effect governing macrophage mTOR signalling and cardiovascular risk. Nature Metabolism 2024.^[32]
• Mannick JB, Lamming DW. Targeting the biology of aging with mTOR inhibitors. Nature Aging 2023.^[33]
• Markova M et al. Similar dietary regulation of IGF-1 and IGF-binding proteins by animal and plant protein in subjects with type 2 diabetes. 2020.^[34]
• Kitada M et al. The regulation of healthspan and lifespan by dietary amino acids. Transl Med Aging 2020.^[35]
• Miller RA et al. Glycine supplementation extends lifespan of male and female mice. Aging Cell 2019.^[36]
• Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Int Soc Sports Nutr 2017.^[37]
• van Galen I et al. High protein intake causes gene-length-dependent transcriptional decline, shortens lifespan and accelerates ageing in progeroid DNA repair-deficient mice. npj Metab Health Dis 2025.^[38]
• Simpson SJ, Raubenheimer D. Protein leverage and the obesity epidemic. 2023 review.^[39]
• Chaix A et al. Time-restricted eating: benefits, mechanisms, and challenges in translation. 2020.^[40]
• Bouvard V et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol 2015 (IARC).^[41]

---